Takeda Estimates Double Digit Sales Increase
This article was originally published in PharmAsia News
Executive Summary
Takeda announced Oct. 20 revised estimated results for the first two fiscal quarters of the year. The company estimates group sales will grow by 13 percent to ¥805 billion from a previous ¥760 billion, business operating income will increase from ¥50 billion to ¥85 billion, and a current earnings increase from ¥50 billion to ¥70 billion. Takada will announce final results Nov. 4. (Click here for more - Japanese language